European Commission

The deal will be formally approved by the EU executive tomorrow

Opdivo plus Yervoy-based combinations now indicated in the EU for three different advanced cancer types: non-small cell lung…

The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020,…

Data from Phase 3 E1912 study showed previously untreated patients aged 70 years or younger treated with ibrutinib plus rituximab…

The approval is based on results from the integrated analysis of the pivotal phase II STARTRK-2, phase I STARTRK-1 and phase I…

The deal is worth $2.1 billion and involves the supply of vaccines for 50 million people, with the option to buy another 500…

Emer Cooke is currently the Director of the Regulation and Prequalification Department at the World Health Organization (WHO) in…

It is planning to spend around $2.3 billion on the advance purchase of vaccines in testing on behalf of the 27 EU states

Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…

A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to…